StonvexLoading…
StonvexStonvexStonvexCore line items from TTEK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-29 | Q4 2025 2025-12-28 | Annual 2025 2025-09-28 | Annual 2025 2025-06-29 |
|---|---|---|---|---|
Revenue | $2.43B | $1.21B | $5.44B | $1.37B |
Operating Income | $272.52M | $140.99M | $408.42M | $164.99M |
Net Income | $199.02M | $105.22M | $247.95M | $119.98M |
EPS (Diluted) | $0.76 | $0.40 | $0.93 | $0.43 |
Total Assets | $4.36B | $4.26B | $4.28B | $4.35B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $223.61M | $269.45M | $167.46M | $242.83M |
Free Cash Flow OCF − CapEx | $227.47M | $68.11M | $439.05M | $343.44M |
Shares Outstanding | 259.52M | 260.81M | 261.42M | 262.75M |